MedTrace Logo

Thrombosis Risk Assessment and Clinical Presentation of Covid-19 Pneumonia

NCT04423315 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 70

Last updated 2020-09-23

No results posted yet for this study

Summary

Covid-19 mainly affects the respiratory system. Multiple organ dysfunction and a particularly progressive respiratory insufficiency along with a widespread coagulopathy presumed to be due to infection-associated inflammation and the resulting cytokine storm, are strongly associated with high mortality rates. In this study, the association between thrombosis risk and clinical presentation of Covid-19 is investigated.

Conditions

  • Corona Virus Infection
  • Thromboembolic Disease

Sponsors & Collaborators

  • Istanbul Nisantasi University

    lead OTHER

Eligibility

Min Age
18 Years
Max Age
99 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-06-08
Primary Completion
2020-07-15
Completion
2020-07-20

Countries

  • Turkey (Türkiye)

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04423315 on ClinicalTrials.gov